Pfizer Agreement NZ – What You Need to Know

Pfizer Inc., the global pharmaceutical giant, has made headlines in New Zealand recently for its agreement with the government to supply the country with COVID-19 vaccines. The deal has been subject to scrutiny and controversy, but what exactly does it entail, and what are the implications for New Zealanders? Let`s take a closer look.

The Agreement

In late 2020, Pfizer reached an agreement with the New Zealand government to supply the country with 1.5 million doses of its COVID-19 vaccine. The agreement includes the option to purchase additional doses if needed. The vaccine, which has been developed in collaboration with German partner BioNTech, has been shown to be highly effective in clinical trials, with a reported efficacy rate of over 90 percent.

The Implications

The Pfizer agreement is a significant development for New Zealand in its fight against COVID-19. The country has been praised internationally for its swift and effective response to the pandemic, with tight border controls and an efficient contact tracing system. However, until now, New Zealand has not had access to any vaccines and has had to rely on these measures alone to keep the virus at bay. The Pfizer agreement changes this, providing the country with a valuable tool in its arsenal against COVID-19.

The Controversy

Despite the potential benefits of the Pfizer agreement, it has not been without controversy. Critics have argued that the deal puts New Zealand at the mercy of a powerful multinational corporation and raises questions about the fairness of access to vaccines in the global marketplace. Others have pointed out that the Pfizer vaccine requires storage at ultra-low temperatures, which could present logistical challenges for New Zealand`s health system.


The Pfizer agreement is a significant development for New Zealand in its fight against COVID-19. While there are legitimate concerns around the deal, its potential benefits cannot be ignored. The vaccine could help to protect New Zealanders from the worst effects of the pandemic and bring the country one step closer to a return to normalcy. As with any health intervention, it is important that the Pfizer vaccine is subject to rigorous safety and efficacy testing, but the signs so far are promising. New Zealanders can take heart that their government is taking the pandemic seriously and is working to keep them safe.